FDA Authorizes 23andMe Direct-to-Consumer BRCA Cancer Test
The test from 23andMe is the first to report on three specific BRCA1/BRCA2 breast cancer gene mutations that are most common in people of Ashkenazi Jewish descent.
Read More
Search Results for: obesity
Treat, but Verify
With tens of thousands of flu cases, more than 10,000 reported hospitalizations, and scores of deaths—including more than 60 young children—this flu season is the worst in a decade and one of the worst on record.
Read More
Agendia Presents Data Demonstrating Value of MammaPrint, BluePrint across Breast Cancer Populations
At the 2017 San Antonio Breast Cancer Symposium, Agendia presented extensive new data highlighting the value of its MammaPrint 70-gene breast cancer risk-of-recurrence test and BluePrint breast cancer molecular subtyping test.
Read More
Ortho Gets FDA Nod for Insulin Reagent, Calibrators
An important biomarker in diabetes and prediabetes testing, the assay is expected to be commercially available for use on all of Ortho’s Vitros immunodiagnostic and integrated systems in the United States during the third quarter of this year.
Read More
ProSciento, Owl Metabolomics Seek to Accelerate Clinical Trial Recruitment
The companies have entered into an exclusive, multiyear partnership to employ noninvasive, lipidomics-based diagnostic testing to establish a database enriched for subjects with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Read More